(Q39280414)

10 September 2017

Aurora kinase B is a potential therapeutic target in pediatric diffuse intrinsic pontine glioma (English)

1 reference

10 September 2017

diffuse midline glioma

0 references

7

Eric Bouffet

1 reference

10 September 2017

3

Ute Bartels

1 reference

10 September 2017

10

Cynthia Hawkins

1 reference

10 September 2017

Pawel Buczkowicz

1

1 reference

10 September 2017

Maryam Zarghooni

2

1 reference

10 September 2017

Andrew Morrison

4

1 reference

10 September 2017

Katherine L Misuraca

5

1 reference

10 September 2017

Tiffany Chan

6

1 reference

10 September 2017

Annie Huang

8

1 reference

10 September 2017

Oren Becher

9

1 reference

10 September 2017

11 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

23

1 reference

10 September 2017

3

1 reference

10 September 2017

244-253

1 reference

The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.

10 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Post mortem examinations in diffuse intrinsic pontine glioma: challenges and chances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Aurora kinase inhibitors--rising stars in cancer therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Advances toward an understanding of brainstem gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Chemotherapy for brain stem gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Diffuse brainstem glioma in children: critical review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

21 January 2018

Aurora kinase inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Shared and separate functions of polo-like kinases and aurora kinases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2012.00633.X

10.1111/J.1750-3639.2012.00633.X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference